Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid aptamer binding to hepatoma cells and its application and detection method using the same

A nucleic acid aptamer, liver cancer cell technology, applied in the field of molecular biomedicine, can solve the problems of low tumor targeting, high immunogenicity, unsuitability, etc., achieves simple detection operation, easy in vitro synthesis and modification, and suitable for wide range of effects

Active Publication Date: 2020-06-12
QINGDAO UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antibodies usually have high affinity to the target, but high immunogenicity; peptides have small molecular weight and are easy to synthesize, but peptides are easy to be enzymatically hydrolyzed in the systemic circulation, so they are not suitable for in vivo application; small molecular compounds, such as folic acid, have small molecular weight and good stability. But the tumor targeting is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid aptamer binding to hepatoma cells and its application and detection method using the same
  • Nucleic acid aptamer binding to hepatoma cells and its application and detection method using the same
  • Nucleic acid aptamer binding to hepatoma cells and its application and detection method using the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Example 1 Screening of nucleic acid aptamers binding to liver cancer cells

[0066] The screening of aptamers is based on the screening of SELEX technology. Synthetic random oligonucleotide ssDNA library GP30 (5'-gcaatggtac ggtacttccn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnc aaaagtgcacgctactttgc taa-3', n represents any one of a, t, c, g),

[0067] Human immortalized liver cell line L-02 was used as subtracted cells, and the library GP30 was incubated with the subtracted cells, and the GP30 library that was not combined with the subtracted cells was incubated with the target cells. The target cells were human HepG2 and SMMC7721 liver cancer cells. , and then wash off the unbound part, elute the ssDNA bound to the target cells, and then amplify and recover by PCR. Repeat the above process for the second round of screening. After several rounds of screening, the enriched library was sequenced at high throughput, connected to the T vector, transformed into Ecoli, and cloned. Pi...

Embodiment 2

[0068] Example 2 Binding detection of nucleic acid aptamers binding to liver cancer cells and target cells

[0069] Cell preparation:

[0070] (a) The day before the experiment was the cell renewal medium, and the medium was high-sugar DMEM medium (gibco) containing 10% fetal bovine serum (Kang Yuan Biology);

[0071] (b) 75cm 2 Cultivate the cells in the culture flask to 70% full, and the cells are in the best growth state, rinse the cells twice with 3mL 1×PBS;

[0072] (c) Digest the cells with 1 mL of trypsin (including EDTA), wait until the cells become round, discard the trypsin, neutralize with 2 mL of complete medium, centrifuge at 1000 rpm for 5 min, and discard the supernatant;

[0073] (d) Wash the cells twice with 10 mL of serum-free DMEM medium, centrifuge at 1000 rpm for 3 min, and discard the supernatant (make sure there is no EDTA residue);

[0074] (e) Resuspend and count in an appropriate volume of washing buffer 1×PBS-1mM MgCl2, take 30,000 cells and put t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a nucleic acid aptamer combined with hepatoma cells and application thereof and a detection method using the same, relating to the technical field of biomedicine. The nucleic acid aptamer combined with hepatoma cells can be specifically combined with hepatoma cells; and with the sequence shown by SEQ ID NO.1, the nucleic acid aptamer combined with nucleic acid has the advantages of accurate identification, no immunogenicity, easiness in in-vitro synthesis and modification, etc. The technical problem that an aptamer capable of targeting hepatocellularcarcinoma cell is unavailable in the prior art is relieved.

Description

technical field [0001] The invention relates to the technical field of molecular biomedicine, in particular to a nucleic acid aptamer binding to liver cancer cells, its application and a detection method using the aptamer. Background technique [0002] Nucleic acid aptamers (aptamers) are folded through hydrogen bond interactions between bases in the chain to form stable secondary or tertiary structures such as hairpins, stem loops, pseudoknots, pockets, convex loops, and G-quadruplexes. The target produces spatially structurally matched ribonucleic acid (RNA) and single-stranded deoxyribonucleic acid (ssDNA) that bind with high affinity and specificity. Nucleic acid aptamers are generally composed of dozens of nucleotides, with small relative molecular mass, easy to penetrate cell membranes, stable properties, easy to prepare and modify; their binding targets range widely, including ions, small molecules, proteins, cells and microorganisms etc.; its affinity can be compara...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/115C12Q1/6806G01N33/574G01N33/569
CPCC12N15/115C12N2310/16C12Q1/6806G01N33/56966G01N33/57438C12Q2531/107
Inventor 葛银林于晓霞葛科立
Owner QINGDAO UNIV